Warning letterFDA · Jul 6, 2020
Lotus Herbal Supplements MARCS-CMS 608658, July 06, 2020
Named company: Lotus Herbal Supplements
Based on our review, this product is an unapproved new drug sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Furthermore, this product is a…
Lot information: not specified in this record.